US Patent Issued to UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION on March 4 for "Methods of lowering the error rate of massively parallel DNA sequencing using duplex consensus sequencing" (Washington Inventors)

ALEXANDRIA, Va., March 5 -- United States Patent no. 12,241,123, issued on March 4, was assigned to UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (Seattle).

"Methods of lowering the error rate of massively parallel DNA sequencing using duplex consensus sequencing" was invented by Jesse Salk (Seattle), Lawrence A. Loeb (Bellevue, Wash.) and Michael Schmitt (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "Next Generation DNA sequencing promises to revolutionize clinical medicine and basic research. However, while this technology has the capacity to generate hundreds of billions of nucleotides of DNA sequence in a single experiment, the error rate of approximately 1% results in hundre...